Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $1.62B | $2.10B | $2.55B |
| Revenue growth | — | 29.9% | 21.5% |
| Gross profit | $315M | $431M | $536M |
| Gross margin | 19.5% | 20.5% | 21.0% |
| Operating income | $10.3M | $70.4M | $61.6M |
| Operating margin | 0.6% | 3.4% | 2.4% |
| Net income | -$46.0M | -$28.6M | -$59.8M |
| Net margin | -2.8% | -1.4% | -2.3% |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | $33.9M | $29.3M | $257M |
| Capital expenditures | $17.1M | $19.0M | $37.9M |
| Free cash flow | $16.8M | $10.3M | $219M |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | — | $81.2M | $230M |
| Total assets | — | $2.35B | $2.68B |
| Total liabilities | — | $2.15B | $1.89B |
| Shareholders' equity | — | — | $392M |
| Retained earnings | — | -$250M | -$310M |
Every figure is extracted from Legence Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.